Success rates in Same Sex Female Couples Undergoing Intrauterine Insemination with Donor Sperm

NEW YORK, Nov. 8, 2017 /PRNewswire/ -- Reproductive Medicine Associates of New York (RMA of NY, www.rmany.com), a fertility center based in Manhattan, presents findings from their research study exploring fertility treatments outcomes of same-sex female couples, single women, and infertile heterosexual couples.  The research was one of a notable 33 scientific abstracts present by RMA of NY and Icahn School of Medicine at Mount Sinai at the 73nd annual meeting of the American Society of Reproductive Medicine (ASRM, www.asrm.com) in San Antonio, Texas.

Dr. Alan B. Copperman, Co-Director of RMA of NY and Vice Chairman of Obstetrics and Gynecology and Director of the Division of Reproductive Endocrinology and Infertility at the Icahn School of Medicine at Mount Sinai Hospital in New York, explains:

"As the modern family construct continues to evolve, it is important for reproductive health care providers to individualize care for each patient's needs. Single women, same sex female couples, and heterosexual couples who seek future childbearing have different reproductive journeys, and we need to personalize care for all."

The RMA of NY study sought to evaluate whether same-sex female couples and single women have comparable clinical outcomes to infertile heterosexual couples when undergoing ovulation induction with oral agents (Letrozole or Clomiphene Citrate) and intrauterine insemination using cryopreserved sperm.

The study identified same-sex female couples and single women to have lower day 3 FSH (8.19 ± 3.4 vs 7.74 ± 3.0, p=0.049) and lower total number of mature follicles (1.82 ± 0.92 vs. 1.69 ± 0.86, p=0.02) as compared to the heterosexual couple cohort, albeit no significant differences was observed in implantation (10.4% vs. 10.0%), ongoing pregnancy (7.2% vs. 7.5%), clinical pregnancy rate (8.3% vs. 8.8%), pregnancy loss rates (31.3% vs 24.6%), or multiple gestation rate (8.3% vs 10.5%). The study did not include the much higher success rates noted in patients undergoing in vitro fertilization and comprehensive chromosomal screening of embryos.

Lead author, Dr. Taraneh Gharib Nazem, a second-year Reproductive Endocrinology and Infertility (REI) Fellow of the Icahn School of Medicine at Mount Sinai, elaborates:

"Given the societal and biological barriers lesbian and single women face in reaching their goal of childbearing, early access to reproductive care may facilitate improved pregnancy outcomes. Reproductive healthcare providers may help empower lesbian and single women to initiate care through community outreach and education about reproductive options."

About Reproductive Medicine Associates of New York, LLP

Reproductive Medicine Associates of New York (RMA of NY) is a global leader in delivering personalized, precise, and compassionate reproductive care. The integrated team of physicians and scientists at RMA of NY has extensive experience and training in reproductive endocrinology, fertility, and urology, and consistently reports high success rates to the Society for Assisted Reproductive Technology (SART) and the Centers for Disease Control and Prevention (CDC). As part of the Icahn School of Medicine at Mount Sinai, RMA of NY performs scientific, educational, and clinical functions. RMA of NY has been recognized as a leader in LGBTQ reproductive care, for women choosing single or same-sex motherhood, and for women and men pursuing fertility preservation for elective and medical indications.

Headquartered in Midtown Manhattan, RMA of NY has three patient care facilities in Manhattan, as well as offices in Brooklyn, Garden City, and White Plains, NY. Additionally, RMA of NY has patient care facilities in Mexico City, Mexico. For more information, visit www.rmany.com.

Media Contact: Allysa Mizerek, Reproductive Medicine Associates of New York, 212-756-5777, [email protected]

SOURCE Reproductive Medicine Associates of New York

Related Links

http://www.rmany.com